hypocalcemia
HYPOCALCEMIA
Hypocalcemia is the occurs when serum calcium concentration is below the lower limit of normal range.
Acute hypocalcemia has neuromuscular tetany as hallmark symptom. Patients have rapid decrease in serum calcium and present with symptomatic hypocalcemia.
It is an emergency condition and requires immediate attention. Ca (IV) should be administered until signs and symptoms abate or until serum Ca levels rise.
Chronic hypocalcemia has asymptomatic mild hypocalcemia. Treatment is necessary to avoid long term complications. Oral Ca may be administered.

Hypocalcemia Drug Information

Drug Information

Indication: Treatment & prevention of vit D deficiency. Adjunctive treatment for osteoporosis. Reduces risk of falling...

Indication: Prevention & treatment of Ca deficiency.

Cebion Vitamin C + Calcium Effervescent Tablet
ascorbic acid + calcium carbonate

Indication: Health supplement.

Proscal
calcium + magnesium + phosphorus + vitamin D3

Indication: Nutritional supplement as a source of Ca for healthy bones.

Redoxon Cal-D
ascorbic acid + calcium + colecalciferol + pyridox...

Indication: Health supplement.

Shine Calcium with Vitamin D Plus
calcium + vitamin D

Indication: Health supplement.

1  /  3
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 28 Nov 2018
A low-carbohydrate diet increases energy expenditure during weight loss maintenance, consistent with the carbohydrate-insulin model, a study has shown. This metabolic effect may contribute to the success of obesity treatment, particularly among those with high insulin secretion.
Natalia Reoutova, 5 days ago

A hospital-based observational cohort study finds an association between higher fasting blood glucose (FBG) levels and unfavourable outcomes, including death, among Chinese patients with diabetes mellitus (DM) following acute ischaemic stroke (AIS).

Elaine Soliven, 6 days ago
Adding liraglutide to metformin led to a significantly longer duration of glycaemic control in patients with type 2 diabetes (T2D) compared with an oral antidiabetic drug (OAD), according to the LIRA-PRIME* study presented at ADA 2020.